MX2018008809A - Anticuerpos monoclonales especificos para el antigeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por adv. - Google Patents
Anticuerpos monoclonales especificos para el antigeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por adv.Info
- Publication number
- MX2018008809A MX2018008809A MX2018008809A MX2018008809A MX2018008809A MX 2018008809 A MX2018008809 A MX 2018008809A MX 2018008809 A MX2018008809 A MX 2018008809A MX 2018008809 A MX2018008809 A MX 2018008809A MX 2018008809 A MX2018008809 A MX 2018008809A
- Authority
- MX
- Mexico
- Prior art keywords
- adv
- monoclonal antibodies
- infection
- useful
- seq
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
La presente invención se refiere a anticuerpos monoclonales, o fragmentos de los mismos, que reconocen la proteína pIII del Adenovirus (ADV), útiles para el desarrollo de métodos de diagnóstico de infección por ADV en humanos. En particular se refiere a un anticuerpo monoclonal o un fragmento de él que comprende una región variable de la cadena pesada que tiene una secuencia con al menos un 90%, 95% o 99% de identidad con la SEQ ID No: 1 o SEQ ID No: 5 y una región variable de la cadena liviana que tiene una secuencia con al menos un 90%, 95% o 99% de identidad con la SEQ ID No: 2 o SEQ ID No: 6. También se dirige a las secuencias nucleotídicas que definen dichos anticuerpos, métodos in vitro y/o ex vivo de diagnóstico de infección por ADV en una muestra biológica que utilizan dichos anticuerpos monoclonales, y kits de diagnóstico para detectar ADV, que comprenden al menos un anticuerpo monoclonal contra ADV de acuerdo a lo descrito anteriormente.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CL2016000164A CL2016000164A1 (es) | 2016-01-21 | 2016-01-21 | Anticuerpos monoclonales específicos para el antígeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por adv. |
| PCT/IB2017/050312 WO2017125892A2 (es) | 2016-01-21 | 2017-01-20 | Anticuerpos monoclonales específicos para el antígeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por adv |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2018008809A true MX2018008809A (es) | 2018-11-29 |
Family
ID=56610130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018008809A MX2018008809A (es) | 2016-01-21 | 2017-01-20 | Anticuerpos monoclonales especificos para el antigeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por adv. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10766948B2 (es) |
| EP (2) | EP3406262B1 (es) |
| CN (1) | CN108697796B (es) |
| AR (1) | AR107440A1 (es) |
| BR (1) | BR112018014538A2 (es) |
| CA (1) | CA3011569A1 (es) |
| CL (1) | CL2016000164A1 (es) |
| ES (1) | ES2898068T3 (es) |
| MX (1) | MX2018008809A (es) |
| PE (1) | PE20181498A1 (es) |
| PT (1) | PT3406262T (es) |
| UY (1) | UY37082A (es) |
| WO (1) | WO2017125892A2 (es) |
| ZA (1) | ZA201804705B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CL2018003869A1 (es) * | 2018-12-28 | 2021-01-15 | Univ Pontificia Catolica Chile | Anticuerpos monoclonales específicos para la proteína quimérica l del virus de la parainfluenza humana (piv), secuencias nucleotídicas; método y kit de diagnóstico de infección producida por piv |
| CN113354727B (zh) * | 2021-08-10 | 2021-11-02 | 北京溯本源和生物科技有限公司 | 一组同时检测b/c/e组腺病毒的单克隆抗体和试纸条 |
| CN116789807B (zh) * | 2023-06-14 | 2024-01-16 | 珠海重链生物科技有限公司 | 抗腺病毒单克隆抗体及其应用 |
| WO2024255566A1 (zh) * | 2023-06-14 | 2024-12-19 | 珠海重链生物科技有限公司 | 抗人腺病毒抗体及其制备方法和应用 |
| CN117586385B (zh) * | 2023-11-23 | 2024-05-17 | 广州医科大学附属第一医院（广州呼吸中心） | 抗人4型腺病毒中和抗体及其制备方法和应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4487829A (en) | 1982-03-23 | 1984-12-11 | Massachusetts Institute Of Technology | Production and use of monoclonal antibodies against adenoviruses |
| US6248514B1 (en) * | 1996-07-09 | 2001-06-19 | Canji, Inc. | Methods for measuring viral infectivity |
| KR100661760B1 (ko) | 1997-08-04 | 2006-12-28 | 가부시끼가이샤 센탈 세메 가가꾸 겐꾸쇼 | 바이러스 검출 또는 검정 방법 |
| US6673614B2 (en) * | 2000-06-27 | 2004-01-06 | Cell Genesys, Inc. | Rapid methods and kits for detection and semi-quantitation of anti-adenovirus antibody |
| CA2414272A1 (en) * | 2000-07-10 | 2002-01-17 | Novartis Ag | Bifunctional molecules and vectors complexed therewith for targeted gene delivery |
| WO2005023848A2 (en) * | 2003-09-09 | 2005-03-17 | Gardner, Rebecca, Katherine | Adenoviral epitopes |
| US7622112B2 (en) | 2003-12-05 | 2009-11-24 | Jody Berry | Anti-SARS monoclonal antibodies |
| US8003108B2 (en) * | 2005-05-03 | 2011-08-23 | Amgen Inc. | Sclerostin epitopes |
| WO2008136774A1 (en) * | 2007-05-03 | 2008-11-13 | Agency For Science, Technology And Research | Antibodies binding to an intracellular prl-1 or prl-3 polypeptide |
-
2016
- 2016-01-21 CL CL2016000164A patent/CL2016000164A1/es unknown
-
2017
- 2017-01-20 CN CN201780007470.2A patent/CN108697796B/zh active Active
- 2017-01-20 US US16/070,730 patent/US10766948B2/en active Active
- 2017-01-20 PE PE2018001294A patent/PE20181498A1/es unknown
- 2017-01-20 AR ARP170100158A patent/AR107440A1/es unknown
- 2017-01-20 CA CA3011569A patent/CA3011569A1/en active Pending
- 2017-01-20 ES ES17741167T patent/ES2898068T3/es active Active
- 2017-01-20 PT PT177411675T patent/PT3406262T/pt unknown
- 2017-01-20 UY UY0001037082A patent/UY37082A/es not_active Application Discontinuation
- 2017-01-20 BR BR112018014538-6A patent/BR112018014538A2/pt active Search and Examination
- 2017-01-20 WO PCT/IB2017/050312 patent/WO2017125892A2/es not_active Ceased
- 2017-01-20 MX MX2018008809A patent/MX2018008809A/es unknown
- 2017-01-20 EP EP17741167.5A patent/EP3406262B1/en active Active
- 2017-01-20 EP EP20166433.1A patent/EP3756685A1/en active Pending
-
2018
- 2018-07-13 ZA ZA2018/04705A patent/ZA201804705B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3406262B1 (en) | 2021-07-28 |
| CL2016000164A1 (es) | 2016-07-29 |
| ES2898068T3 (es) | 2022-03-03 |
| EP3406262A4 (en) | 2019-01-09 |
| WO2017125892A3 (es) | 2018-04-12 |
| CN108697796A (zh) | 2018-10-23 |
| PE20181498A1 (es) | 2018-09-18 |
| ZA201804705B (en) | 2019-09-25 |
| CN108697796B (zh) | 2023-01-10 |
| EP3756685A1 (en) | 2020-12-30 |
| WO2017125892A2 (es) | 2017-07-27 |
| PT3406262T (pt) | 2021-11-03 |
| UY37082A (es) | 2017-04-28 |
| CA3011569A1 (en) | 2017-07-27 |
| US10766948B2 (en) | 2020-09-08 |
| EP3406262A2 (en) | 2018-11-28 |
| BR112018014538A2 (pt) | 2018-12-26 |
| AR107440A1 (es) | 2018-05-02 |
| US20190048065A1 (en) | 2019-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2619707T3 (es) | Péptidos terapéuticos | |
| MX2018008809A (es) | Anticuerpos monoclonales especificos para el antigeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por adv. | |
| JP2015533788A5 (es) | ||
| PE20071055A1 (es) | Anticuerpos anti mn | |
| JP2017518366A5 (es) | ||
| AR084210A1 (es) | PROTEINAS DE UNION AL TNF-a | |
| BR112013008765B8 (pt) | Anticorpos monoclonais anti-tau humano isolados ou um fragmento de ligação à tau dos mesmos, métodos de preparação dos mesmos, polinucleotídeo ou polinucleotídeos, vetor ou vetores, composição, método in vitro de diagnóstico ou monitoramento da progressão de uma tauopatia neurodegenerativa em um indivíduo humano, método in vitro para diagnosticar uma tauopatia neurodegenerativa em um indivíduo humano, e kit útil para o diagnóstico de uma tauopatia neurodegenerativa | |
| RU2014101707A (ru) | АНТИ-Axl АНТИТЕЛА И ИХ ПРИМЕНЕНИЕ | |
| FR2933773B1 (fr) | Procede de dosage de la proteine disulfide isomerase pour le diagnostic in vitro du cancer colorectal | |
| RU2011121818A (ru) | Способ иммунологического анализа белка cxcl1 человека | |
| NZ594682A (en) | Fully human antibodies specific to cadm1 | |
| ES2563955T3 (es) | Método para identificar linfocitos T reguladores | |
| PE20220004A1 (es) | Anticuerpos monoclonales especificos para el antigeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por vrsh | |
| RU2016116773A (ru) | Способ выявления опухоли поджелудочной железы, антитела и набор для выявления опухоли поджелудочной железы | |
| JP2018507254A5 (es) | ||
| JP2018515071A5 (es) | ||
| EP4300101A3 (en) | Antigenic peptides and uses thereof for diagnosing and treating autism | |
| MX2023004212A (es) | Conjugados reactivos. | |
| WO2014192974A1 (ja) | 抗ｌｇｒ６抗体を含む癌の検出用又は診断用試薬 | |
| GB2547603B (en) | Specific monoclonal antibodies of the antigen M of the human metapneumovirus (HMPV) and use thereof in a diagnostic method | |
| WO2019118906A3 (en) | Monoclonal antibodies targeting phf1 and at8 epitopes of human tau protein | |
| WO2015078711A3 (en) | Methods, peptides and antibodies for preventing, treating and diagnosing an inflammatory condition | |
| GB0616929D0 (en) | Antibodies, assays and hybridomas | |
| WO2012029990A1 (ja) | 大腸がんマーカーに対する抗体 | |
| EA200901590A1 (ru) | Антитела, применяемые в терапии и диагностике рака |